Centessa Pharmaceuticals (CNTA)
(Delayed Data from NSDQ)
$17.02 USD
-0.16 (-0.93%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $17.00 -0.02 (-0.12%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Centessa Pharmaceuticals PLC Sponsored ADR has a market cap of $2.30B, which represents its share price of $17.18 multiplied by its outstanding shares number of 133.62M. As a mid-cap company, CNTA's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CNTA 17.02 -0.16(-0.93%)
Will CNTA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CNTA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CNTA
Centessa Pharmaceuticals (CNTA) Upgraded to Buy: What Does It Mean for the Stock?
Wall Street Analysts Think Centessa Pharmaceuticals (CNTA) Could Surge 138.77%: Read This Before Placing a Bet
CNTA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for CNTA
Centessa Pharmaceuticals (CNTA) Maintains Buy Rating and $30 PT | CNTA Stock News
Alkermes narcolepsy trial results 'encouraging' for Centessa, says Leerink
Centessa Pharmaceuticals (CNTA) Gains Coverage with a 'Buy' Rating | CNTA Stock News
Truist Initiates Coverage on Centessa (CNTA) with Promising Outlook | CNTA Stock News
Centessa initiated with bullish view at Truist, here's why